Transnasal and standard transoral endoscopies in the screening of gastric mucosal neoplasias

doi:10.4253/wjge.v3.i8.162

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3005)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-4) series.

Item

Count

PDF

355

HTML

2386

Tables (1-4)

264

Sum=3005

Aug 16, 2011 (publication date) through Feb 4, 2025

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Endoscopy

ISSN

1948-5190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastrointest Endosc. Aug 16, 2011; 3(8): 162-170
Published online Aug 16, 2011. doi: 10.4253/wjge.v3.i8.162

Table 1 Clinical profiles of the subjects screened by transnasal or transoral endoscopy and clinicopathological characteristics of detected gastric mucosal neoplasia (mean ± SD) n (%)

		Subject screened
	Total subjects	By transnasal EGD	By transoral EGD
No. of screened subjects	3324	1382	1942
Age (yr)	53.4 ± 15.4	53.4 ± 15.4	53.5 ± 15.4
Males	1442 (43.4)	684 (49.4)^a	758 (39.0)
Smokers	678 (20.4)	267 (19.3)	411 (21.1)
Helicobacter pylori-infected subjects	1202 (40.2)	510 (39.8)	692 (40.5)
CAG-positive subjects	1360 (40.9)	560 (40.5)	800 (41.2)
No. of subjects with gastric neoplasia/DR	55/0.0165	23/0.0166	32/0.0165
Location of neoplasia (U/M/L)	20/15/20	8/7/8	12/8/12
Adenoma cases/DR	12/0.0036	3/0.0022	9/0.0046
Location of adenoma (U/M/L)	2/4/6	0/2/1	2/2/5
Size of adenoma (mm)	10.5 ± 7.0	9.7 ± 4.0	10.8 ± 7.9
Cancer cases/DR	43/0.0129	20/0.0145	23/0.0118
Location of cancer (U/M/L)	18/11/14	8/5/7	10/6/7
Size of cancer (mm)	27.3 ± 16.7	32.6 ± 19.5^a	22.3 ± 12.8
Morphological cancer type (I-IIa/IIb/IIc-III/Ad)	12/1/15/13	6/1/5/8	6/0/12/5
With intestinal-type cancer	33 (76.7)	18 (90.0)^a	15 (65.2)
Depth of invasion (m/sm/pm-)	20/10/13	5/7/8	15/3/5
With early cancer	30 (69.7)	12 (60.0)	18 (78.3)

^aP < 0.05 vs transoral esophagogastroduodenoscopy (EGD). CAG: Chronic atrophic gastritis; DR: Detection rate; U: Upper third of the stomach; M: Middle third of the stomach; L: Lower third of the stomach.

Citation: Nakata H, Enomoto S, Maekita T, Inoue I, Ueda K, Deguchi H, Shingaki N, Moribata K, Maeda Y, Mori Y, Iguchi M, Tamai H, Yamamichi N, Fujishiro M, Kato J, Ichinose M. Transnasal and standard transoral endoscopies in the screening of gastric mucosal neoplasias. World J Gastrointest Endosc 2011; 3(8): 162-170
URL: https://www.wjgnet.com/1948-5190/full/v3/i8/162.htm
DOI: https://dx.doi.org/10.4253/wjge.v3.i8.162